Skip to main content

Table 5 Treatment modality by primary diagnosis

From: Late somatic sequelae after treatment of childhood cancer in Slovenia

Treatment

Primary diagnosis

S

RT

CHT

S_RT

S_CHT

RT_CHT

S_RT_CHT

Leukemia

0.6%

1.1%

27.0%

0.6%

0.0%

70.1%

0.6%

NHL

2.3%

3.4%

25.3%

3.4%

16.1%

41.4%

8.0%

Neuroblastoma

37.5%

4.2%

0.0%

8.3%

25.0%

4.2%

20.8%

Other malignant neoplasms

40.0%

2.9%

2.9%

20.0%

25.7%

0.0%

8.6%

Rhabdomyosarcoma

2.9%

0.0%

0.0%

0.0%

20.6%

29.4%

47.1%

HD

0.0%

5.7%

4.1%

8.9%

1.6%

59.3%

20.3%

CNS

31.9%

3.5%

0.0%

35.4%

2.1%

2.8%

24.3%

Soft-tissue sarcomas

24.6%

0.0%

0.0%

10.8%

50.8%

1.5%

12.3%

Malignant bone tumors

3.9%

0.0%

0.0%

7.8%

60.8%

13.7%

13.7%

Other carcinomas

60.0%

2.9%

0.0%

18.6%

5.7%

4.3%

8.6%

Renal tumors

2.2%

0.0%

0.0%

11.1%

40.0%

0.0%

46.7%

  1. The influence of the primary diagnosis on the treatment modality.